These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 15375658)
1. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Köbel M; Weichert W; Crüwell K; Schmitt WD; Lautenschläger C; Hauptmann S Virchows Arch; 2004 Nov; 445(5):456-64. PubMed ID: 15375658 [TBL] [Abstract][Full Text] [Related]
2. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732 [TBL] [Abstract][Full Text] [Related]
4. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD44v6 has no prognostic value in patients with colorectal cancer. Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731 [TBL] [Abstract][Full Text] [Related]
6. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
8. CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis. Wang JL; Su WY; Lin YW; Xiong H; Chen YX; Xu J; Fang JY Oncotarget; 2017 Feb; 8(8):12866-12876. PubMed ID: 28030817 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383 [TBL] [Abstract][Full Text] [Related]
10. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression. Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763 [TBL] [Abstract][Full Text] [Related]
11. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Afify A; Purnell P; Nguyen L Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378 [TBL] [Abstract][Full Text] [Related]
12. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Herrera-Gayol A; Jothy S Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969 [TBL] [Abstract][Full Text] [Related]
13. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma. Wang L; Liu Q; Lin D; Lai M Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744 [TBL] [Abstract][Full Text] [Related]
14. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN; Mirejovský T; Melinová L; Mandys V Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866 [TBL] [Abstract][Full Text] [Related]
15. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117 [TBL] [Abstract][Full Text] [Related]
16. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221 [TBL] [Abstract][Full Text] [Related]
17. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Ropponen K; Tammi M; Parkkinen J; Eskelinen M; Tammi R; Lipponen P; Agren U; Alhava E; Kosma VM Cancer Res; 1998 Jan; 58(2):342-7. PubMed ID: 9443415 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer. Xie JW; Chen PC; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Lin Y; Huang CM J Cancer Res Clin Oncol; 2015 Oct; 141(10):1809-17. PubMed ID: 25809905 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of CD44v6, bcl-2, and vascular endothelial growth factor(VEGF) in endometrial adenocarcinoma]. Xiang DJ; Xue WQ; Feng YZ; Lu YN; Chen PQ; Wang JY Ai Zheng; 2003 Jun; 22(6):592-6. PubMed ID: 12948407 [TBL] [Abstract][Full Text] [Related]
20. CD44V6 expression in human colorectal carcinoma. Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]